{"id":29562,"date":"2025-06-12T20:32:29","date_gmt":"2025-06-12T20:32:29","guid":{"rendered":"http:\/\/medexperts.pro\/?p=29562"},"modified":"2025-06-12T21:30:15","modified_gmt":"2025-06-12T21:30:15","slug":"elon-musks-xai-is-getting-250-million-in-investments-from-tpg-sequoia-and-others","status":"publish","type":"post","link":"https:\/\/medexperts.pro\/?p=29562","title":{"rendered":"Elon Musk\u2019s xAI Is Getting $250 Million in Investments From TPG, Sequoia and Others"},"content":{"rendered":"<div><\/div>\n<p id=\"article-summary\" class=\"css-79rysd e1wiw3jv0\">Two dozen venture capital firms and other investors are investing in xAI, the artificial intelligence and social media company.<\/p>\n<section class=\"meteredContent css-1r7ky0e\">\n<div class=\"css-s99gbd StoryBodyCompanionColumn\" data-testid=\"companionColumn-0\">\n<div class=\"css-53u6y8\">\n<p class=\"css-at9mc1 evys1bk0\">Two dozen venture capital firms and other investors are buying about $250 million worth of shares in xAI, the artificial intelligence and social media company controlled by Elon Musk, according to internal documents seen by The New York Times.<\/p>\n<p class=\"css-at9mc1 evys1bk0\">Current and former employees of xAI, which acquired the social media company X in March, could sell a portion of their shares to investors including TPG, ARK Invest and Sequoia Capital under a deal known as a tender offer, according to the internal documents. Fidelity, a previous investor in Mr. Musk\u2019s companies, is purchasing $20 million worth of shares in the deal, which values xAI at $113 billion, the documents show.<\/p>\n<p class=\"css-at9mc1 evys1bk0\">The tender offer is separate from <a class=\"css-yywogo\" href=\"https:\/\/www.nytimes.com\/2025\/05\/08\/technology\/xai-elon-musk-funding-value.html\" title>other talks held by xAI<\/a>, in which investors have discussed putting as much as $20 billion into the company at a valuation of up to $120 billion.<\/p>\n<p class=\"css-at9mc1 evys1bk0\">Earlier this year, Mr. Musk said <a class=\"css-yywogo\" href=\"https:\/\/www.nytimes.com\/2025\/03\/28\/technology\/musk-x-xai.html\" title>he was merging xAI with X<\/a>, formerly known as Twitter, which he bought in late 2022 for $44 billion. A generative A.I. company, xAI developed the chatbot Grok, which competes with OpenAI\u2019s ChatGPT.<\/p>\n<\/div>\n<\/div>\n<div data-testid=\"Dropzone-1\"><\/div>\n<div class=\"css-s99gbd StoryBodyCompanionColumn\" data-testid=\"companionColumn-1\">\n<div class=\"css-53u6y8\">\n<p class=\"css-at9mc1 evys1bk0\">Many investors in the tender offer have previously invested in Mr. Musk\u2019s companies, including the electric vehicle manufacturer Tesla and the rocket company SpaceX.<\/p>\n<p class=\"css-at9mc1 evys1bk0\">Fidelity previously invested in Mr. Musk\u2019s deal to buy Twitter. It had marked down its valuation of the social media company to less than $10 billion last year, according to public documents.<\/p>\n<p class=\"css-at9mc1 evys1bk0\">Human Capital, a small Bay Area venture firm, is also investing. Its co-founder Baris Akis became heavily <a class=\"css-yywogo\" href=\"https:\/\/www.nytimes.com\/2025\/01\/29\/us\/politics\/elon-musk-trump-administration.html\" title>involved with the presidential transition<\/a> after Mr. Musk stumped for President Trump and became a close adviser.<\/p>\n<p class=\"css-at9mc1 evys1bk0\">A spokesman for xAI did not respond to a request for comment. Representatives for Fidelity, TPG, ARK Invest, Sequoia Capital and Human Capital did not respond to requests for comment.<\/p>\n<\/div>\n<\/div>\n<div data-testid=\"RelatedLinksBlock-3\">\n<div data-testid=\"lazy-loader\"><\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Two dozen venture capital firms and other investors are investing in xAI, the artificial intelligence and social media company.Two dozen venture capital firms and other investors are buying about $250 million worth of shares in xAI, the artificial intelligence and social media company controlled by Elon Musk, according to internal documents seen by The New York Times.Current and former employees of xAI, which acquired the social media company X in March, could sell a portion of their shares to investors including TPG, ARK Invest and Sequoia Capital under a deal known as a tender offer, according to the internal documents. Fidelity, a previous investor in Mr. Musk\u2019s companies, is purchasing $20 million worth of shares in the deal, which values xAI at $113 billion, the documents show.The tender offer is separate from other talks held by xAI, in which investors have discussed putting as much as $20 billion into the company at a valuation of up to $120 billion.Earlier this year, Mr. Musk said he was merging xAI with X, formerly known as Twitter, which he bought in late 2022 for $44 billion. A generative A.I. company, xAI developed the chatbot Grok, which competes with OpenAI\u2019s ChatGPT.Many investors in the tender offer have previously invested in Mr. Musk\u2019s companies, including the electric vehicle manufacturer Tesla and the rocket company SpaceX.Fidelity previously invested in Mr. Musk\u2019s deal to buy Twitter. It had marked down its valuation of the social media company to less than $10 billion last year, according to public documents.Human Capital, a small Bay Area venture firm, is also investing. Its co-founder Baris Akis became heavily involved with the presidential transition after Mr. Musk stumped for President Trump and became a close adviser.A spokesman for xAI did not respond to a request for comment. Representatives for Fidelity, TPG, ARK Invest, Sequoia Capital and Human Capital did not respond to requests for comment.<\/p>\n","protected":false},"author":1,"featured_media":29564,"comment_status":"close","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-29562","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology"],"_links":{"self":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/29562","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=29562"}],"version-history":[{"count":2,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/29562\/revisions"}],"predecessor-version":[{"id":29565,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/29562\/revisions\/29565"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/media\/29564"}],"wp:attachment":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=29562"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=29562"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=29562"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}